Alginate derived oligosaccharide G-block as a new drug candidate in the treatment of cystic fibrosis.
OligoG is a new, inhaled dual-acting drug candidate developed from alginate. It is being developed for the treatment of cystic fibrosis. This project aims to progress the project until end of phase 2 and to evaluate lung deposition of OligoG using gamma scintigraphy and pharmacokinetic profiling.
4 375 180.00€
Clinical Research, Trials